MRM Health develops therapeutics based on optimized consortia of live bacteria, utilizing their proprietary CORAL® platform for microbiome therapeutics. The company focuses on inflammatory bowel diseases and has preclinical programs in various conditions.

MRM Health

Viewport Meta

IPhone / Mobile Compatible

Google Font API

Google Maps

Mobile Non Scaleable Content

Chief Executive Officer

Sam Possemiers

Director Pharmaceutical Development and Manufacturing

Selin Bolca

Senior Associate Scientist

David Campos

Head of Scientific Operations

Hannah Dewerchin

Head of Translational Research Unit

Iris Pinheiro

Senior Scientist

Jolien Souffriau

Maksine Franceus

Principal Scientist

Erwin Swinnen

Ron Robison

Gregoire Franoux

Katja Conrath

Chief Scientific Officer

CEO & Co-Founder

Biotechnology Companies With Less Than $10M in Revenue (Top 10K)

Europe Health Care Companies (Top 10K)

Health Care Companies With Less Than $10M in Revenue (Top 10K)

Biotechnology Companies (Top 10K)

MRM Health NV, is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health was incorporated early 2020 by MRM Technologies, a Center of Expertise for microbiome research based in the biotech cluster in Ghent, in a joint venture with the Flemish Institute of Biotechnology (VIB), an excellence-based entrepreneurial life sciences research institute in Flanders, Belgium, that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications.

Agentschap Innoveren & Ondernemen

Grant - MRM Health NV

SFPIM

Venture Round - MRM Health NV

Series A - MRM Health NV

Ghent

Oost-Vlaanderen

Belgium

Europe

MRM Health NV

MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors

MRM Health to Present Positive Clinical Data from MH002 in Ulcerative Colitis at Digestive Disease Week (DDW)

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002

MRM Health Initiates Clinical Research in Parkinson’s Disease

MRM Health Appoints Katja Conrath as Chief Scientific Officer

A technology platform for developing microbial therapeutics by identifying and integrating key therapeutic strains into optimized consortia.

Novel class of microbial therapeutics developed using the CORAL® platform, designed for disease-specific therapeutic effects.

Advanced simulator of the human gut used for modeling intestinal processes and evaluating microbiome therapeutics.

Includes completed and ongoing trials in Ulcerative Colitis and Pouchitis, focusing on immune modulation and restoration.

Research initiatives in CNS disorders, metabolic diseases (Type 2 Diabetes and NAFLD/NASH), and auto-immune diseases.

Lead clinical program for treating Ulcerative Colitis, evaluated in a multi-center, double-blind, randomized, placebo-controlled trial.

The Netherlands

India

Asia

Brazil

South America

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 6:33 AM	47accbf9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 6:33 AM	94c5054a
crunchbase trigger	general	Nov 19, 2024 6:33 AM	c3f99ac1
crunchbase profile	general	Nov 20, 2024 12:29 AM	10b7aee1
li profile	general	Nov 19, 2024 6:33 AM	df8f2390
translate crunchbase fundingrounds	general	Nov 20, 2024 1:21 AM	5674ebba
peers	general	Nov 19, 2024 6:33 AM	8636e088
news basic	general	Nov 19, 2024 6:33 AM	8e9d9ba0
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

MRMH

COM:MRMHEALTH

MRM Health